Loading...

Digitalization And Global Expansion Will Secure Enduring Value

Published
24 Nov 24
Updated
27 Mar 26
Views
254
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
5.2%
7D
3.8%

Author's Valuation

€36.876.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 27 Mar 26

Fair value Increased 0.35%

G: Mixed Broker Views And Dividend Plans Will Guide Measured Forward Upside

Analysts have made a modest upward adjustment to the Assicurazioni Generali price target to about €36.87, reflecting mixed recent research in which some firms raised targets toward €38 to €38.50 while others trimmed estimates, alongside updated assumptions on growth, margins and a slightly lower future P/E.

Analyst Commentary

Bullish Takeaways

  • Bullish analysts highlight that recent price targets in the €38 to €38.50 range suggest room for upside relative to the current average target, which may appeal if you think Generali can deliver on its plans.
  • The resumption of a Buy rating signals confidence in the company’s ability to execute, with focus on earnings delivery and capital discipline to support that higher valuation range.
  • Higher targets from some firms, even when lifted only modestly, point to a view that Generali’s current P/E can be justified if management meets expectations on profitability and cash generation.
  • Supportive ratings and higher targets in close succession indicate that a group of bullish analysts see the risk or reward balance as attractive at recent levels.

Bearish Takeaways

  • JPMorgan’s decision to trim its price target by €1 underlines that not all analysts are comfortable with the current valuation, especially with updated assumptions on growth and margins.
  • Hold ratings tied to targets around €38 suggest some bearish analysts view the shares as fairly valued, with limited upside unless execution clearly exceeds expectations.
  • The mixed pattern of target raises and cuts, clustered around a relatively narrow price band, signals caution about how much more multiple expansion the shares might support.
  • Adjustments that factor in a slightly lower future P/E show that some bearish analysts are building in more conservative scenarios, which could cap target prices if sentiment or results weaken.

What's in the News

  • Assicurazioni Generali announced an annual dividend of €1.64 per share, with an ex dividend date set for May 18, 2026, a record date on May 19, 2026, and payment scheduled for May 20, 2026 (Key Developments).

Valuation Changes

  • Fair Value has been updated to €36.87 from €36.75, reflecting a modest upward adjustment in underlying assumptions.
  • The Discount Rate is now 9.01% versus 8.99%, having edged up slightly and implying a marginally higher required return in the model.
  • Revenue Growth has been updated to 25.55% from 25.06%, lifted slightly and pointing to a small change in expected top line expansion in € terms.
  • The Net Profit Margin is now 4.60% compared with 4.49%, adjusted slightly higher and indicating a minor revision to expected profitability on € earnings.
  • The Future P/E has been reduced to 13.25x from 14.47x, falling meaningfully and suggesting the valuation model now applies a lower earnings multiple to Generali’s projected results.
1 viewusers have viewed this narrative update

Key Takeaways

  • Digital transformation and AI integration are enhancing efficiency, pricing, and underwriting, driving operational improvements and stable margins.
  • Diversification into high-growth markets and sustainability initiatives are strengthening revenue streams and improving stability and reputation.
  • Heavy reliance on government bonds, underperformance in key segments, and rising capital requirements threaten margins, growth prospects, capital efficiency, and shareholder returns.

Catalysts

About Assicurazioni Generali
    Provides various insurance solutions under the Generali brand in the Americas, Italy, rest of Europe, Africa, the Middle East, Asia, and the Oceania.
What are the underlying business or industry changes driving this perspective?
  • Continued premium growth and margin expansion in the Life and Protection, Health & Accident segments, supported by demographic shifts like an aging population in Europe, position Generali for sustained revenue and earnings growth as long-term demand for retirement and health solutions increases.
  • Strategic investments in digitalization and artificial intelligence are enhancing distribution efficiency, pricing sophistication, and underwriting capabilities, setting Generali up for future improvements in operational efficiency, lower expense ratios, and resilient net margins.
  • Expansion and strong growth in Central Eastern Europe and select Asian markets are diversifying the revenue base towards higher-growth geographies, creating multi-year tailwinds for top-line and earnings growth and mitigating sluggishness in mature Western European markets.
  • Ongoing focus on growing the capital-light and fee-based asset management segment, as evidenced by strong inflows and improved margins, is expected to increase net profit stability and boost return on equity over the medium to long term.
  • Emphasis on sustainability in operations and investment-alongside leadership in protection products and ESG integration-should improve Generali's reputation among institutional investors, facilitate access to lower-cost capital, and help safeguard long-term profitability.

Assicurazioni Generali Earnings and Revenue Growth

Assicurazioni Generali Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Assicurazioni Generali's revenue will grow by 25.5% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 7.2% today to 4.6% in 3 years time.
  • Analysts expect earnings to reach €5.3 billion (and earnings per share of €3.52) by about March 2029, up from €4.2 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as €4.7 billion.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.3x on those 2029 earnings, up from 12.2x today. This future PE is greater than the current PE for the GB Insurance industry at 12.2x.
  • Analysts expect the number of shares outstanding to decline by 0.98% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 9.01%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Persistently low reinvestment yields and the company's reliance on government bonds-especially the noted increase in Italian government debt exposure-could constrain investment income and compress net margins over time if interest rates remain volatile or suppressed.
  • The direct insurance channel in Italy is currently running at an undiscounted combined ratio of 105% and is less profitable than in the past, which, if not effectively turned around, may weigh on overall earnings and reduce the projected positive impact from digitalization.
  • Expansion outside of Europe, particularly in Asia, is triggering higher Solvency II capital requirements due to regulatory non-equivalence, potentially depressing Solvency ratios and restricting capital efficiency, which could impair long-term earnings and hinder growth targets.
  • Industry pricing cycles-especially in non-motor, health, and global corporate/commercial lines-are described as entering softer phases in certain regions, which, if not counteracted by sufficient risk premium spreads, could pressure revenue growth and operating margins.
  • Cash remittances and capital release from certain markets such as Switzerland remain subdued until at least 2026–2027, constraining immediate cash flow and possibly affecting dividend/distribution policies or reinvestment capacity, thus limiting short
  • to medium-term growth in shareholder returns.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €36.87 for Assicurazioni Generali based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €43.4, and the most bearish reporting a price target of just €28.5.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €114.4 billion, earnings will come to €5.3 billion, and it would be trading on a PE ratio of 13.3x, assuming you use a discount rate of 9.0%.
  • Given the current share price of €33.75, the analyst price target of €36.87 is 8.5% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Assicurazioni Generali?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives